Efficacy And Safety In 15 Hemophilia B Patients Treated With The Aav Gene Therapy Vector Fidanacogene Elaparvovec And Followed For At Least 1 Year
Lindsey A. George,Spencer K. Sullivan,John E.J. Rasko,Adam Giermasz,Benjamin J. Samelson-Jones,Jonathan M. Ducore,Jerome M. Teitel,Catherine E. McGuinn,Alexa R. Runowski,Fraser Wright,Xavier M. Anguela,Katherine A. High,Denis Rybin, John E. Murphy,Jeremy Rupon BLOOD（2019）
AI 理解论文
溯源树
样例
